Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Business Of Biotech
00:00
The Microbiome and the Life Sciences Business
I was early on convinced that it was potentially something big in terms of changing the way we're going to be approaching and met medical need. The most important for me was that I'm the son of two parents, diagnosed with a cancer. When I've created the company, there was no drug approved at all in the world. So I said, that is what I want to do. And that's now nine years. With the mad farmer, I've never spent so long in the company. But today for me, it's obvious. Now that I've found what I was looking for without knowing it, I'm not willing to change anymore.
Transcript
Play full episode
